Poxviridae FINAL

Embed Size (px)

Citation preview

  • 8/6/2019 Poxviridae FINAL

    1/21

    Poxviridae Introduction

    Poxviruses are the largest and mostcomplex of viruses. The family

    encompasses a large group of agents that

    are similar morphologically and share a

    common nucleoprotein antigen.

    Infections with most poxviruses are

    characterized by a rash, although lesions

    induced by some members of the family

    Even though smallpox was declarederadicated from the world (in 1980) after an

    intensive campaign coordinated by the

    World Health Organization, there is

    concern that the virus could be reintroduced

    as a biologic weapon.

  • 8/6/2019 Poxviridae FINAL

    2/21

  • 8/6/2019 Poxviridae FINAL

    3/21

    Structure & Composition Poxviruses are large enough to be seen as

    featureless particles by light microscopy.

    By electron microscopy, they appear to be

    brick-shaped measuring about 400 x 230

    nm. Their structure is complex andconforms to neither icosahedral nor helical

    symmetry. The external surface of

    particles contains ridges.

    There is an outer lipoprotein membrane, or

    envelope, that encloses a core and two

    structures of unknown function called

    lateral bodies

  • 8/6/2019 Poxviridae FINAL

    4/21

    Classification

    Poxviruses are divided into two subfamilies based on whether

    they infect vertebrate or insect hosts.

    The vertebrate poxviruses fall into eight genera, with the

    members of a given genus displaying similar morphology and

    host range as well as some antigenic relatedness.

    Most of the poxviruses that can cause disease in humans are

    contained in the genera Orthopoxvirus and Parapoxvirus;

    there are also several that are classified in the genera

    Yatapoxvirus and Molluscipoxvirus (Table 2)

  • 8/6/2019 Poxviridae FINAL

    5/21

    Table 2. Poxviruses Causing Disease in Humans.

    Genus Virus Primary Host Disease

    Orthopoxvirus Variola Humans Smallpox (now eliminated)

    Vaccinia Humans Localized lesion; used for

    smallpox vaccination

    Buffalopox Water buffalo Human infections rare; localized

    lesion

    Monkeypox Rodents, monkeys Human infections rare;

    generalized disease

    Cowpox Cows Human infections rare; localizedulcerating lesion

    Parapoxvirus Orf Sheep Human infections rare; localized

    lesionPseudocowpox Cows

    Bovine papular stomatitis Cows

    Molluscipoxvirus Molluscum contagiosum Humans Many benign skin nodules

    Yatapoxvirus Tanapox Monkeys Human infections rare; localized

    lesion

    Yabapox Monkeys Human infections very rare and

    accidental; localized skin tumors

  • 8/6/2019 Poxviridae FINAL

    6/21

    Poxvirus ReplicationThe replication cycle of vaccinia virus is

    summarized in Figure. Poxviruses are

    unique among DNA viruses in that the

    entire multiplication cycle takes place in

    the cytoplasm of infected cells. It is

    possible, however, that nuclear factors

    may be involved in transcription andvirion assembly. Poxviruses are further

    distinguished from all other animal

    viruses by the fact that the uncoating step

    requires a newly synthesized, virus-

    encoded protein.The "uncoating" protein that acts on the cores is among the more than

    50 polypeptides made early after infection. The second-stage

    uncoating step liberates viral DNA from the cores; it requires both

    RNA and protein synthesis. The synthesis of host cell macromoleculesis inhibited at this stage.

  • 8/6/2019 Poxviridae FINAL

    7/21

  • 8/6/2019 Poxviridae FINAL

    8/21

    Pathogenesis & Pathology of Smallpox

    The portal of entry of variola virus was the mucous membranes of

    the upper respiratory tract. After viral entry, the following are

    believed to have taken place: (1) primary multiplication in the

    lymphoid tissue draining the site of entry; (2) transient viremia and

    infection of reticuloendothelial cells throughout the body; (3) a

    secondary phase of multiplication in those cells, leading to (4) a

    secondary, more intense viremia; and (5) the clinical disease. By the sixth to ninth days, lesions in the mouth tended to ulcerate

    and discharge virus. Thus, early in the disease, infectious virus

    originated in lesions in the mouth and upper respiratory tract. Later,

    pustules broke down and discharged virus into the environment of

    the smallpox patient.

    Histopathologic examination of the skin showed proliferation of the

    prickle-cell layer. Those proliferated cells contained many

    cytoplasmic inclusions with mononuclear cells,

  • 8/6/2019 Poxviridae FINAL

    9/21

    Pathogenesis & Pathology of Smallpox

    Clinical Findings

    The incubation period of variola (smallpox) was 1014 days. The onset was usually sudden. One to 5 days of fever and malaise

    preceded the appearance of the exanthems, which began as macules,

    then papules, then vesicles, and finally pustules.

    These formed crusts that fell off after about 2 weeks, leaving pinkscars that faded slowly. In each affected area, the lesions were

    generally found in the same stage of development (in contrast to

    chickenpox).

    A "Smallpox Recognition Card" prepared by the World Health

    Organization shows the typical rash. Lesions were most abundant on

    the face and less so on the trunk. In severe cases, the rash was

    hemorrhagic. The case-fatality rate varied from 5% to 40%. In mild

    variola, called variola minor, or in vaccinated persons, the mortality

    rate was under 1%.

  • 8/6/2019 Poxviridae FINAL

    10/21

    Immunity All viruses within the Orthopoxvirus genus are so closely related

    antigenically that they cannot be easily differentiated serologically.

    Infection with one induces an immune response that reacts with all

    other members of the group.

    An attack of smallpox gave complete protection against reinfection.

    Vaccination with vaccinia induced immunity against variola virus for

    at least 5 years and sometimes longer. Antibodies alone are notsufficient for recovery from primary poxvirus infection. In the human

    host, neutralizing antibodies develop within a few days after onset of

    smallpox but do not prevent progression of lesions, and patients may

    die in the pustular stage with high antibody levels. Cell-mediated

    immunity is probably more important than circulating antibody..

  • 8/6/2019 Poxviridae FINAL

    11/21

    Laboratory Diagnosis

    Several tests are available to

    confirm the diagnosis of

    smallpox. Now that thedisease is presumably

    eradicated, it is important to

    diagnose any cases that

    resemble smallpox. The tests

    depend upon direct

    microscopic examination of

    material from skin lesions,

    recovery of virus from the

    patient, identification ofviral DNA or antigen from

    the lesion, and, least

    importantly, demonstration

    of antibody in the blood.

  • 8/6/2019 Poxviridae FINAL

    12/21

    Picornaviruses Picornaviruses represent a very large virus family with respect to

    the number of members but one of the smallest in terms of virion

    size and genetic complexity.

    They include two major groups of human pathogens:

    enteroviruses and rhinoviruses. Enteroviruses are transient

    inhabitants of the human alimentary tract and may be isolated

    from the throat or lower intestine.

    Rhinovirus Group

    Rhinoviruses are the common cold viruses. They are the most

    commonly recovered agents from people with mild upper

    respiratory illnesses. They are usually isolated from nasalsecretions but may also be found in throat and oral secretions.

    These virusesas well as coronaviruses, adenoviruses,

    enteroviruses, parainfluenza viruses, and influenza viruses

    cause upper respiratory tract infections, including the common

  • 8/6/2019 Poxviridae FINAL

    13/21

    Table 3. Important Properties of Picornaviruses.

    Virion: Icosahedral, 2830 nm in diameter, contains 60 subunits

    Composition: RNA (30%), protein (70%)

    Genome: Single-stranded RNA, linear, positive-sense, 7.28.4 kb in size, MW 2.5

    million, infectious, contains genome-linked protein (VPg)

    Proteins: Four major polypeptides cleaved from a large precursor polyprotein.

    Surface capsid proteins VP1 and VP3 are major antibody-binding sites. VP4 is aninternal protein.

    Envelope: None

    Replication: Cytoplasm

    Outstanding characteristics: Family is made up of many enterovirus and rhinovirus

    types that infect humans and lower animals, causing various illnesses ranging from

    poliomyelitis to aseptic meningitis to the common cold.

  • 8/6/2019 Poxviridae FINAL

    14/21

    Rhinovirus

    Classification

    Human rhinovirus isolates are numbered sequentially.More than 100 species are known. Isolates within a

    species share more than 70% sequence identity within

    certain protein-coding regions.

    Human rhinoviruses can be divided into major and minor

    receptor groups. Viruses of the major group use

    intercellular adhesion molecule-1 (ICAM-1) as receptor

    and those of the minor group bind members of the low-

    density lipoprotein receptor (LDLR) family.

  • 8/6/2019 Poxviridae FINAL

    15/21

    Pathogenesis The virus enters via the upper respiratory tract.

    High titers of virus in nasal secretionswhich can be

    found as early as 24 days after .

    Thereafter, viral titers fall, although illness persists. In

    some instances, virus may remain detectable for 3 weeks.

    There is a direct correlation between the amount of virusin secretions and the severity of illness.

    Replication is limited to the surface epithelium of the nasal

    mucosa. Biopsies have shown that histopathologic changes

    are limited to the submucosa and surface epithelium.These include edema and mild cellular infiltration. Nasal

    secretion increases in quantity and in protein

    concentration.

    Rhinoviruses rarely cause lower respiratory tract disease.

  • 8/6/2019 Poxviridae FINAL

    16/21

    Immunity

    Neutralizing antibody to the infecting virus develops in serum an

    secretions of most persons(ranged from 37% to over 90%).

    Antibody develops 721 days after infection; the time of

    appearance of neutralizing antibody in nasal secretions parallels

    that of serum antibodies. Because recovery from illness usually

    precedes appearance of antibodies, it seems that recovery is not

    dependent on antibody.

    However, antibody may accomplish final clearance of infection.

    Serum antibody persists for years but decreases in titer.

    Treatment & Control

    No specific prevention method or treatment is available.

    Antiviral drugs are thought to be a more likely control measure for

    rhinoviruses because of the problems with vaccine development.

    A 5-day course of high doses of intranasal interferon-alfa has been

    shown to be effective in preventing the spread of rhinoviruses .

  • 8/6/2019 Poxviridae FINAL

    17/21

    Orthomyxoviruses Introduction

    Respiratory illnesses are responsible for more than half of all

    acute illnesses each year in the United States.

    TheOrthomyxoviridae (influenza viruses) are a major

    determinant of morbidity and mortality caused by respiratory

    disease, and outbreaks of infection sometimes occur in

    worldwide epidemics.

    Influenza has been responsible for millions of deaths

    worldwide.

    Influenza type A is antigenically highly variable and isresponsible for most cases of epidemic influenza. Influenza type

    B may exhibit antigenic changes and sometimes causes

    epidemics. Influenza type C is antigenically stable and causes

    only mild illness in immunocompetent individuals

  • 8/6/2019 Poxviridae FINAL

    18/21

    Table3. Important Properties of Orthomyxoviruses.1

    Virion: Spherical, pleomorphic, 80120 nm in diameter (helical nucleocapsid, 9 nm)

    Composition: RNA (1%), protein (73%), lipid (20%), carbohydrate (6%)

    Genome: Single-stranded RNA, segmented (eight molecules), negative-sense, 13.6 kb

    overall size

    Proteins: Nine structural proteins, one nonstructural

    Envelope: Contains viral hemagglutinin (HA) and neuraminidase (NA) proteins

    Replication: Nuclear transcription; capped 5' termini of cellular RNA scavenged as

    primers; particles mature by budding from plasma membrane

    Outstanding characteristics:

    Genetic reassortment common among members of the same genus

    Influenza viruses cause worldwide epidemics

  • 8/6/2019 Poxviridae FINAL

    19/21

  • 8/6/2019 Poxviridae FINAL

    20/21

  • 8/6/2019 Poxviridae FINAL

    21/21

    A comparison of influenza A virus with other viruses that infect the human respiratory tract is shown in Table 393. Influenza virus is

    considered here.

    Table -4. Comparison of Viruses that Infect the Human Respiratory Tract.Virus Disease Number of Serotypes Lifelong

    Immunity

    to Disease

    Vaccine

    Available

    Viral Latency

    RNAviruses

    Influenza A virus Influenza Many No + -

    Parainfluenza virus Croup Many No - -

    Respiratory syncytial virus Bronchiolitis One No - -

    Rubella virus Rubella One Yes + -

    Measles virus Measles One Yes + -

    Mumps virus

    Parotitis, meningitis One Yes + -

    Rhinovirus Common cold Many No - -

    Coronavirus Common cold Many No - -

    CoxsackievirusHerpangina, pleurodynia Many No - -

    DNAviruses

    Herpes simplex virus type 1 Gingivostomatitis One No - +

    Epstein-Barr virusInfectious mononucleosis One Yes - +

    Varicella-zoster virusChickenpox, shingles One

    Yes1+ +

    AdenovirusPharyngitis, pneumonia Many No - +